{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:07:52Z","timestamp":1760216872735},"reference-count":60,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chemistry and Physics of Lipids"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.chemphyslip.2003.10.003","type":"journal-article","created":{"date-parts":[[2003,12,31]],"date-time":"2003-12-31T06:00:10Z","timestamp":1072850410000},"page":"125-133","source":"Crossref","is-referenced-by-count":25,"title":["Isoprostanes and the liver"],"prefix":"10.1016","volume":"128","author":[{"given":"Kevin","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.chemphyslip.2003.10.003_BIB1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0925-4439(02)00225-9","article-title":"Oxidant stress is a significant feature of primary biliary cirrhosis","volume":"1637","author":"Aboutwerat","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.chemphyslip.2003.10.003_BIB2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1530-0277.1999.tb04028.x","article-title":"Polyenylphosphatidylcholine opposes the increase of cytochrome P-4502E1 by ethanol and corrects its iron-induced decrease","volume":"23","author":"Aleynik","year":"1999","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.chemphyslip.2003.10.003_BIB3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1530-0277.1998.tb03637.x","article-title":"Increased circulating products of lipid peroxidation in patients with alcoholic liver disease","volume":"22","author":"Aleynik","year":"1998","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.chemphyslip.2003.10.003_BIB4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/labinvest.3780227","article-title":"Centrilobular endothelial cell injury by diquat in the selenium deficient rat liver","volume":"81","author":"Atkinson","year":"2001","journal-title":"Lab. Invest."},{"issue":"6","key":"10.1016\/j.chemphyslip.2003.10.003_BIB5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jn\/124.6.810","article-title":"Detection and localization of lipid peroxidation in selenium-and vitamin E-deficient rats using F2-isoprostanes","volume":"124","author":"Awad","year":"1994","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.chemphyslip.2003.10.003_BIB6","first-page":"858","article-title":"Effect of selenium deficiency and glutathione-modulating age on diquat toxicity and lipid peroxidation in rats","volume":"270","author":"Awad","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.chemphyslip.2003.10.003_BIB7","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/00000542-199604000-00019","article-title":"Demonstration of halothane-induced hepatitis lipid peroxidation in rats by quantification of F2-isoprostanes","volume":"84","author":"Awad","year":"1996","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.chemphyslip.2003.10.003_BIB8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.STR.0000055763.76479.E6","article-title":"Selective neuromicrovascular endothelial cell death by 8-iso-prostaglandin F2alpha: possible role in ischemic brain injury","volume":"34","author":"Brault","year":"2003","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.chemphyslip.2003.10.003_BIB9","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1074\/jbc.275.4.2499","article-title":"Specific analysis in plasma and urine of 2,3-dinor-5, 6-dihydro-isoprostane F(2alpha)-III, a metabolite of isoprostane F(2alpha)-III and an oxidation product of gamma-linolenic acid","volume":"275","author":"Burke","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.chemphyslip.2003.10.003_BIB10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00007890-200207270-00012","article-title":"A prospective analysis of oxidative stress and liver transplantation","volume":"74","author":"Burke","year":"2002","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.chemphyslip.2003.10.003_BIB11","doi-asserted-by":"crossref","first-page":"E1406","DOI":"10.1152\/ajpendo.2000.279.6.E1406","article-title":"Vitamin C suppresses oxidative lipid damage in vivo, even in presence of iron overload","volume":"279","author":"Chen","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.chemphyslip.2003.10.003_BIB12","first-page":"623","article-title":"Antilipid mediator and antioxidant therapy in adult respiratory distress syndrome","volume":"1","author":"Christman","year":"1993","journal-title":"New Horiz."},{"issue":"Pt 3","key":"10.1016\/j.chemphyslip.2003.10.003_BIB13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1042\/bj3000799","article-title":"The effect of iron overload on rat plasma and liver oxidant in vivo","volume":"300","author":"Dabbagh","year":"1994","journal-title":"J. Biochem."},{"issue":"11","key":"10.1016\/j.chemphyslip.2003.10.003_BIB14","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1161\/01.CIR.95.11.2492","article-title":"8-Epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo","volume":"95","author":"Delanty","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.chemphyslip.2003.10.003_BIB15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/hep.510280314","article-title":"N-Acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat","volume":"28","author":"Fernando","year":"1998","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.chemphyslip.2003.10.003_BIB16","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1046\/j.1523-1755.2003.00008.x","article-title":"Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients","volume":"63","author":"Ferraro","year":"2003","journal-title":"Kidney Int."},{"issue":"6 Pt. 1","key":"10.1016\/j.chemphyslip.2003.10.003_BIB17","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1152\/ajpcell.1993.264.6.C1619","article-title":"Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells","volume":"264","author":"Fukunaga","year":"1993","journal-title":"Am. J. Physiol."},{"issue":"Suppl. 3","key":"10.1016\/j.chemphyslip.2003.10.003_BIB18","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/00005344-199526003-00016","article-title":"Stimulatory effect of 8-epi-PGF2 alpha, an F2-isoprostane, on endothelin-1 release","volume":"26","author":"Fukunaga","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"4 Pt 2","key":"10.1016\/j.chemphyslip.2003.10.003_BIB19","first-page":"F477","article-title":"Evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2","volume":"272","author":"Fukunaga","year":"1997","journal-title":"Am. J. Physiol."},{"issue":"5","key":"10.1016\/j.chemphyslip.2003.10.003_BIB20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/hep.510270504","article-title":"Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage","volume":"27","author":"Goulis","year":"1998","journal-title":"Hepatology"},{"issue":"9147","key":"10.1016\/j.chemphyslip.2003.10.003_BIB21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(98)06020-6","article-title":"Bacterial infection in the pathogenesis of variceal bleeding","volume":"353","author":"Goulis","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.chemphyslip.2003.10.003_BIB22","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/hep.510300515","article-title":"Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic rat","volume":"30","author":"Harry","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.chemphyslip.2003.10.003_BIB23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0090-6980(97)00004-X","article-title":"Effect of the isoprostanes 8-iso prostaglandin E2 and 8-iso prostaglandin F2 alpha on the rabbit lung in vivo","volume":"53","author":"Hill","year":"1997","journal-title":"Prostaglandins"},{"issue":"5\/6","key":"10.1016\/j.chemphyslip.2003.10.003_BIB24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0891-5849(98)00250-0","article-title":"Increased urinary F2-isoprostane excretion in alcoholic liver disease","volume":"26","author":"Hill","year":"1999","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.chemphyslip.2003.10.003_BIB25","doi-asserted-by":"crossref","first-page":"R391","DOI":"10.1152\/ajpregu.2001.281.2.R391","article-title":"2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite","volume":"281","author":"Hou","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol"},{"issue":"3","key":"10.1016\/j.chemphyslip.2003.10.003_BIB26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5414\/CNP58190","article-title":"Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients","volume":"58","author":"Ikizler","year":"2002","journal-title":"Clin. Nephrol."},{"issue":"6","key":"10.1016\/j.chemphyslip.2003.10.003_BIB27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0168-8278(02)00060-0","article-title":"Oxidative stress in chronic hepatitis C: not just a feature of late stage disease","volume":"36","author":"Jain","year":"2002","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.chemphyslip.2003.10.003_BIB28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.bjp.0703784","article-title":"Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles","volume":"132","author":"Janssen","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.chemphyslip.2003.10.003_BIB29","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1476-5381.1996.tb16033.x","article-title":"Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha","volume":"119","author":"Kromer","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"5 Pt 2","key":"10.1016\/j.chemphyslip.2003.10.003_BIB30","first-page":"R1406","article-title":"A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels","volume":"274","author":"Lahaie","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.chemphyslip.2003.10.003_BIB31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1054-3589(08)61001-7","article-title":"Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases","volume":"38","author":"Lieber","year":"1997","journal-title":"Adv. Pharmacol."},{"issue":"2","key":"10.1016\/j.chemphyslip.2003.10.003_BIB32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1530-0277.1997.tb03776.x","article-title":"Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon","volume":"21","author":"Lieber","year":"1997","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.chemphyslip.2003.10.003_BIB33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0016-5085(97)70237-3","article-title":"8-Isoprostaglandin F2 alpha, a product of lipid peroxidation, increases portal pressure in normal and cirrhotic rats","volume":"112","author":"Marley","year":"1997","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.chemphyslip.2003.10.003_BIB34","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0891-5849(94)90191-0","article-title":"Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia","volume":"16","author":"Mathews","year":"1994","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.chemphyslip.2003.10.003_BIB35","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI5584","article-title":"Alcohol-induced generation of lipid peroxidation products in humans","volume":"104","author":"Meagher","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.chemphyslip.2003.10.003_BIB36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0952-3278(98)90095-3","article-title":"In vivo effect of 8-epi-PGF2alpha on retinal circulation in diabetic and non-diabetic rats","volume":"59","author":"Michoud","year":"1998","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"4","key":"10.1016\/j.chemphyslip.2003.10.003_BIB37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0168-8278(02)00208-8","article-title":"Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study","volume":"37","author":"Montalto","year":"2002","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.chemphyslip.2003.10.003_BIB38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/cs0920433","article-title":"The hepatorenal syndrome","volume":"92","author":"Moore","year":"1997","journal-title":"Clin. Sci. (Lond.)"},{"issue":"6","key":"10.1016\/j.chemphyslip.2003.10.003_BIB39","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/10715769809065821","article-title":"Measurement of lipid peroxidation","volume":"28","author":"Moore","year":"1998","journal-title":"Free Radic. Res."},{"issue":"25","key":"10.1016\/j.chemphyslip.2003.10.003_BIB40","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1056\/NEJM199212173272502","article-title":"Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome","volume":"327","author":"Moore","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"48","key":"10.1016\/j.chemphyslip.2003.10.003_BIB41","doi-asserted-by":"crossref","first-page":"31731","DOI":"10.1074\/jbc.273.48.31731","article-title":"A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure","volume":"273","author":"Moore","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.chemphyslip.2003.10.003_BIB42","doi-asserted-by":"crossref","first-page":"10721","DOI":"10.1073\/pnas.89.22.10721","article-title":"Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids","volume":"89","author":"Morrow","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.chemphyslip.2003.10.003_BIB43","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1172\/JCI116143","article-title":"Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation","volume":"90","author":"Morrow","year":"1992","journal-title":"J. Clin. Invest."},{"issue":"18","key":"10.1016\/j.chemphyslip.2003.10.003_BIB44","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199505043321804","article-title":"Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage","volume":"332","author":"Morrow","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.chemphyslip.2003.10.003_BIB45","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\/3","key":"10.1016\/j.chemphyslip.2003.10.003_BIB46","first-page":"417","article-title":"Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome","volume":"6","author":"Morrow","year":"1993","journal-title":"J. Lipid Mediat."},{"issue":"2","key":"10.1016\/j.chemphyslip.2003.10.003_BIB47","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/abio.1999.4008","article-title":"Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay","volume":"269","author":"Morrow","year":"1999","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.chemphyslip.2003.10.003_BIB48","first-page":"1280","article-title":"Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease","volume":"269","author":"Nanji","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.chemphyslip.2003.10.003_BIB49","first-page":"832","article-title":"Cimetidine prevents alcoholic hepatic injury in the intragastric feeding rat model","volume":"269","author":"Nanji","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.chemphyslip.2003.10.003_BIB50","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1073\/pnas.95.7.3449","article-title":"IPF2alpha-I: an index of lipid peroxidation in humans","volume":"95","author":"Pratico","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.chemphyslip.2003.10.003_BIB51","first-page":"51","article-title":"Enhanced lipid peroxidation in hepatic cirrhosis","volume":"46","author":"Pratico","year":"1998","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.chemphyslip.2003.10.003_BIB52","first-page":"27","article-title":"Formation of 8-iso-prostaglandin F2 alpha by human platelets","volume":"45","author":"Pratico","year":"1995","journal-title":"Agents Actions Suppl."},{"issue":"9","key":"10.1016\/j.chemphyslip.2003.10.003_BIB53","first-page":"430","article-title":"Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients","volume":"46","author":"Pratico","year":"1998","journal-title":"J. Investig. Med."},{"issue":"10","key":"10.1016\/j.chemphyslip.2003.10.003_BIB54","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1161\/01.CIR.96.10.3314","article-title":"Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans","volume":"96","author":"Reilly","year":"1997","journal-title":"Circulation"},{"issue":"34","key":"10.1016\/j.chemphyslip.2003.10.003_BIB55","doi-asserted-by":"crossref","first-page":"20617","DOI":"10.1074\/jbc.271.34.20617","article-title":"Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans","volume":"271","author":"Roberts","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.chemphyslip.2003.10.003_BIB56","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1054-8807(01)00095-3","article-title":"Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells","volume":"10","author":"Ruef","year":"2001","journal-title":"Cardiovasc. Pathol."},{"issue":"4","key":"10.1016\/j.chemphyslip.2003.10.003_BIB57","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1046\/j.1523-1755.2001.00976.x","article-title":"Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis","volume":"60","author":"Salahudeen","year":"2001","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.chemphyslip.2003.10.003_BIB58","first-page":"155","article-title":"Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphatics","volume":"30","author":"Sinzinger","year":"1997","journal-title":"Lymphology"},{"issue":"3","key":"10.1016\/j.chemphyslip.2003.10.003_BIB59","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0008-6363(99)00225-4","article-title":"Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia","volume":"44","author":"Wilson","year":"1999","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.chemphyslip.2003.10.003_BIB60","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1523-1755.1999.00596.x","article-title":"Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells","volume":"56","author":"Yura","year":"1999","journal-title":"Kidney Int."}],"container-title":["Chemistry and Physics of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000930840300152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000930840300152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T16:26:07Z","timestamp":1550247967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000930840300152X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":60,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S000930840300152X"],"URL":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2003.10.003","relation":{},"ISSN":["0009-3084"],"issn-type":[{"value":"0009-3084","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}